On Wednesday, Stifel Nicolaus raised its IQVIA price target to $303 from $276 and maintained a buy rating. The firm cited an improving market backdrop, IQVIA’s strengthening market position, and higher win rates. Stifel’s new target implies more than 16% upside from the stock’s current price.
JPMorgan raised its price target to $295 from $285. IQVIA recently reported quarterly earnings of $3.15 per share, above analysts’ consensus estimate of $3.03. Its shares have climbed significantly over the past six months.